Literature DB >> 15754740

Thyroid, hemostasis and thrombosis.

F Marongiu1, C Cauli, S Mariotti.   

Abstract

The aim of this paper is to briefly review some practical aspects of the relationship between thyroid function and several disorders of the hemostatic system in terms of bleeding and thrombosis. Thrombocytopenia, acquired hemophilia, hypercoagulability, cardioembolism and other biochemical coagulative and fibrinolytic abnormalities have been described in the past years both in hyper- and hypothyroidism. Since most of hyper- and hypothyroid conditions are the consequence of autoimmune thyroid disease (1), either deranged immune function, altered circulating thyroid hormone concentration, or both may concur in the pathogenesis of hemostatic disorders of potential crucial clinical impact. These aspects will be outlined and discussed in an attempt to give answers to some questions, often arising in the clinical approach.

Entities:  

Mesh:

Year:  2004        PMID: 15754740     DOI: 10.1007/BF03345311

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  74 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

Authors:  J Auer; P Scheibner; T Mische; W Langsteger; O Eber; B Eber
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

3.  Graves disease associated with autoimmune thrombocytopenic purpura.

Authors:  L C Hofbauer; C Spitzweg; S Schmauss; A E Heufelder
Journal:  Arch Intern Med       Date:  1997-05-12

Review 4.  ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.

Authors:  G Y Lip; G D Lowe
Journal:  BMJ       Date:  1996-01-06

5.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

6.  Apathetic Graves' disease and acquired hemophilia due to factor VIIIc antibody.

Authors:  F Marongiu; C Cauli; G Mameli; B Usai; S Mariotti
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

7.  Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol.

Authors:  J Burggraaf; S Lalezari; J J Emeis; U M Vischer; P H de Meyer; H Pijl; A F Cohen
Journal:  Thyroid       Date:  2001-02       Impact factor: 6.568

8.  Antiphospholipid antibody syndrome complicated by Grave's disease.

Authors:  Ayumi Takahashi; Atsushi Tamura; Osamu Ishikawa
Journal:  J Dermatol       Date:  2002-12       Impact factor: 4.005

9.  Management of atrial fibrillation in the post-thyrotoxic state.

Authors:  H K Nakazawa; K Sakurai; N Hamada; N Momotani; K Ito
Journal:  Am J Med       Date:  1982-06       Impact factor: 4.965

10.  Activation of blood coagulation and fibrinolysis in Graves' disease.

Authors:  F Marongiu; M Conti; M L Murtas; G Mameli; G G Sorano; E Martino
Journal:  Horm Metab Res       Date:  1991-12       Impact factor: 2.936

View more
  11 in total

Review 1.  Thyroid-associated autoimmune coagulation disorders.

Authors:  Massimo Franchini; Giuseppe Lippi; Franco Manzato; Pier Paolo Vescovi
Journal:  J Thromb Thrombolysis       Date:  2009-03-10       Impact factor: 2.300

2.  Negative association between free triiodothyronine level and international normalized ratio in euthyroid subjects with acute myocardial infarction.

Authors:  Li Li; Chang-yan Guo; Jing Yang; En-zhi Jia; Tie-bing Zhu; Lian-sheng Wang; Ke-jiang Cao; Wen-zhu Ma; Zhi-jian Yang
Journal:  Acta Pharmacol Sin       Date:  2011-10-03       Impact factor: 6.150

3.  German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease.

Authors:  Thomas J Musholt; Thomas Clerici; Henning Dralle; Andreja Frilling; Peter E Goretzki; Michael M Hermann; Jochen Kussmann; Kerstin Lorenz; Christoph Nies; Jochen Schabram; Peter Schabram; Christian Scheuba; Dietmar Simon; Thomas Steinmüller; Arnold W Trupka; Robert A Wahl; Andreas Zielke; Andreas Bockisch; Wolfram Karges; Markus Luster; Kurt W Schmid
Journal:  Langenbecks Arch Surg       Date:  2011-03-22       Impact factor: 3.445

4.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

5.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; İrfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

Review 6.  The coagulation system in endocrine disorders: a narrative review.

Authors:  A Squizzato; V E A Gerdes; W Ageno; H R Büller
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

Review 7.  Coagulation and fibrinolysis in thyroid dysfunction.

Authors:  Cihangir Erem
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

8.  [Safety and effectiveness of total hip arthroplasty in patients with hypothyroidism].

Authors:  Mingcheng Yuan; Qiang Xiao; Zichuan Ding; Tingxian Ling; Zongke Zhou
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-10-15

Review 9.  Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.

Authors:  Arash Ordookhani; Kenneth D Burman
Journal:  Int J Endocrinol Metab       Date:  2017-03-09

10.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor and thrombomodulin levels in children with hypothyroidism.

Authors:  Bülent Alioğlu; Nevin Kılıç; Enver Şimşek; Yıldız Dallar
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.